Lonza Group AG (LZAGF) Financials
LZAGF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 23.9 billion | 12.3 billion |
| June 30, 2025 | 23.7 billion | 12.8 billion |
| Dec. 31, 2024 | 21.8 billion | 11.4 billion |
| June 30, 2024 | 19.9 billion | 9.4 billion |
LZAGF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | 103.4 million | ? |
| June 30, 2025 | -370.8 million | 40.4 million |
| Dec. 31, 2024 | -28.8 million | ? |
| June 30, 2024 | -129.9 million | ? |
LZAGF Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | 609.1 million |
| June 30, 2025 | 537.3 million |
| Dec. 31, 2024 | 340.6 million |
| June 30, 2024 | 365.4 million |
LZAGF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 906.2 million | - | 447.4 million |
| June 30, 2025 | 1.1 billion | - | - |
| Dec. 31, 2024 | 1.9 billion | - | 453.4 million |
| June 30, 2024 | 2.2 billion | - | - |
LZAGF Shares Outstanding
LZAGF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 884.0 million | - | - | - |
| June 30, 2025 | 847.6 million | - | - | - |
| Dec. 31, 2024 | 879.1 million | 227.8 million | 161.4 million | 286.4 million |
| June 30, 2024 | 690.8 million | - | 599.7 million | 127.7 million |
LZAGF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 3.7 billion | 2.5 billion |
| June 30, 2025 | 4.5 billion | 2.9 billion |
| Dec. 31, 2024 | 3.9 billion | 2.7 billion |
| June 30, 2024 | 3.4 billion | 2.2 billion |
LZAGF
Price: $633.54
Dividend Yield: 0.51%
Forward Dividend Yield: 0.83%
Payout Ratio: 47.83%
Dividend Per Share: 5.22 USD
Earnings Per Share: 16.82 USD
P/E Ratio: 36.83
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 44.1 billion
Average Dividend Frequency: 1
Years Paying Dividends: 27
DGR3: 30.00%
DGR5: 22.43%
DGR10: 12.35%
DGR20: 11.45%